LIVEREF Trademark

Trademark Overview


On Wednesday, November 15, 2023, a trademark application was filed for LIVEREF with the United States Patent and Trademark Office. The USPTO has given the LIVEREF trademark a serial number of 98271407. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 30, 2024. This trademark is owned by Cytel Inc.. The LIVEREF trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory genetic testing, medical diagnostic testing, and pharmacogenetics; Pharmaceutical research services; Pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for conducting pharmaceutical research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparatio...
liveref

General Information


Serial Number98271407
Word MarkLIVEREF
Filing DateWednesday, November 15, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2024

Trademark Statements


Goods and ServicesConsulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory genetic testing, medical diagnostic testing, and pharmacogenetics; Pharmaceutical research services; Pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for conducting pharmaceutical research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing on-line nondownloadable software for conducting pharmaceutical research

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 20, 2023
Primary Code042
First Use Anywhere DateWednesday, August 31, 2022
First Use In Commerce DateWednesday, August 31, 2022

Trademark Owner History


Party NameCytel Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameCytel Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, June 21, 2024ASSIGNED TO EXAMINER
Friday, June 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 18, 2023NEW APPLICATION ENTERED